Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

1700006A11Rik Activators

1700006A11Rik Activators encompass a diverse array of chemical compounds that indirectly influence the functional activity of 1700006A11Rik across various cellular signaling pathways. For example, Forskolin, by increasing cAMP levels, activates PKA, which could directly phosphorylate 1700006A11Rik or modify its regulatory protein interactions, thereby enhancing its activity. PMA mimics DAG and activates PKC, potentially resulting in phosphorylation events that activate 1700006A11Rik. Ionomycin facilitates calcium influx, triggering calcium-dependent kinases that might phosphorylate and activate 1700006A11Rik. Similarly, Sphingosine 1-phosphate signals through its receptors, potentially impacting 1700006A11Rik activation states via downstream phosphorylation events. The tyrosine kinase inhibition by Genistein could diminish competitive signaling, potentially enhancing pathways that activate 1700006A11Rik. LY294002 and U0126, by inhibiting PI3K and MEK1/2, respectively, could alter intracellular signaling, leading toactivation of 1700006A11Rik through alternative routes. SB203580 alters p38 MAPK activity, potentially favoring 1700006A11Rik activation, while EGCG's kinase inhibition could similarly streamline signaling towards 1700006A11Rik enhancement.

On the other hand, A23187 (Calcimycin) and Rapamycin act through the modulation of intracellular calcium and mTOR inhibition respectively, which may lead to the engagement of 1700006A11Rik in calcium-dependent pathways or autophagy-related processes. Staurosporine, despite general kinase inhibition, may relieve negative regulatory constraints on 1700006A11Rik, leading to its activation. Collectively, these activators utilize a broad spectrum of biochemical mechanisms to facilitate enhanced activity of 1700006A11Rik, leveraging direct and indirect modulation of cellular signaling pathways without necessitating the upregulation of gene expression or direct protein activation. Each chemical operates within a unique facet of cellular biochemistry, ensuring that 1700006A11Rik is engaged and functionally active, underpinning its diverse roles in cellular physiology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA functions as a diacylglycerol (DAG) analogue, activating protein kinase C (PKC) which can phosphorylate and thus, activate 1700006A11Rik if it is a substrate or involved in associated signaling pathways.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Ionomycin acts as an ionophore that increases intracellular calcium levels, potentially activating calcium-dependent protein kinases which can phosphorylate and thereby enhance the activity of 1700006A11Rik.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$162.00
$316.00
$559.00
$889.00
$1693.00
7
(1)

Sphingosine 1-phosphate binds to its G-protein-coupled receptors, initiating a signaling cascade that could culminate in the activation of 1700006A11Rik through phosphorylation or allosteric interactions.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein is an inhibitor of tyrosine kinases, which may lead to a reduction in competitive signaling pathways, thereby enhancing signaling processes that activate 1700006A11Rik.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor, which can alter the PI3K/AKT pathway, potentially resulting in the activation of 1700006A11Rik by changing the phosphorylation dynamics within the cell.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is a p38 MAPK inhibitor, which could shift signaling dynamics to favor alternative pathways that activate 1700006A11Rik through phosphorylation or other regulatory mechanisms.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG can inhibit multiple kinases, potentially reducing competitive signaling and enhancing pathways that lead to the activation of 1700006A11Rik.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

A23187 acts as a calcium ionophore, raising intracellular calcium levels and potentially activating calcium-dependent signaling pathways that could enhance the activity of 1700006A11Rik.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine, though a broad-spectrum kinase inhibitor, could paradoxically activate 1700006A11Rik by inhibiting kinases that negatively regulate it.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits mTOR, which could activate autophagy-related pathways where 1700006A11Rik might be involved, leading to its functional activation.